Improving diabetes education with real-time glucose monitoring
Enhancing Digitally Delivered Diabetes Education With Real-Time CGM: A Comparative Study in People With Type 2 Diabetes
This study is testing whether using a Continuous Glucose Monitoring device along with a text messaging program can help people with Type 2 Diabetes who don’t use insulin manage their condition better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 140 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Scripps Whittier Diabetes Institute Academic / other |
| Locations | 1 site (San Diego, California) |
| Trial ID | NCT06296550 on ClinicalTrials.gov |
What this trial studies
This research investigates the effectiveness of adding Continuous Glucose Monitoring (CGM) devices to a text messaging diabetes education program for patients with Type 2 Diabetes who are not on insulin therapy. The study will last for 6 months and aims to enhance diabetes self-management by providing real-time insights into glycemic control. Participants will receive the Dulce Digital text messaging intervention alongside the CGM device, which is typically not available to non-insulin users. The goal is to assess the clinical and financial benefits of this combined approach.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with Type 2 Diabetes who are not using insulin therapy and have an A1c between 7.5% and 12.0%.
Not a fit: Patients currently using insulin therapies or those already utilizing a CGM device will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve diabetes management and self-care for patients with Type 2 Diabetes.
How similar studies have performed: While the use of CGM devices in diabetes management is established, this specific approach of combining CGM with text messaging education for non-insulin users is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with type 2 diabetes * Are not currently using a CGM * Are not using insulin therapies * Speak English, Spanish or Arabic * Have A1c between 7.5% and 12.0% in last 90 days * Have a cellphone that can receive/send text messages and counts steps Exclusion Criteria: * Are using insulin therapies * Are pregnant * Are currently using a CGM * Are currently participating in another diabetes-related study
Where this trial is running
San Diego, California
- Scripps Whittier Diabetes Institute — San Diego, California, United States (Recruiting)
Study contacts
- Principal investigator: Athena Philis-Tsimikas, MD — Scripps Health
- Study coordinator: Kallie Brown, PhD
- Email: brown.kallie@scrippshealth.org
- Phone: 858-258-3555
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.